Related Experiment Video

Updated: Jul 13, 2026

2-Vessel Occlusion/Hypotension: A Rat Model of Global Brain Ischemia
09:29

2-Vessel Occlusion/Hypotension: A Rat Model of Global Brain Ischemia

Published on: June 22, 2013

19.9K

Reperfusion of ischemia in the heart or brain

Victor Gurewich1, David Segarnick2

  • 1Department of Medicine, Harvard Medical School, Cambridge, Massachusetts.

The Journal of Pharmacology and Experimental Therapeutics
|February 10, 2025
PubMed

Insights

Acute myocardial infarction (AMI) treatment using percutaneous coronary intervention (PCI) has delays impacting mortality. A sequential combination of tissue-type plasminogen activator and prourokinase offers a more effective reperfusion therapy for AMI and stroke.

Area of Science:

  • Cardiovascular Medicine
  • Thrombosis and Fibrinolysis

Background:

  • Percutaneous coronary intervention (PCI) is the standard treatment for acute myocardial infarction (AMI).
  • PCI procedures are lengthy (2-3 hours) and unsuitable for small artery clots.
  • Inpatient catheterization for PCI causes reperfusion delays, directly correlating with increased AMI mortality.

Purpose of the Study:

  • To evaluate an alternative treatment for AMI that overcomes PCI limitations.
  • To explore a fibrinolytic therapy that mimics the body's natural clot-busting process.

Main Methods:

  • The study focuses on a sequential combination therapy using tissue-type plasminogen activator and prourokinase.
  • This approach aims to directly address the fibrinolytic process involved in AMI and ischemic stroke.

Main Results:

  • The sequential fibrinolytic combination demonstrates effectiveness in treating AMI and ischemic stroke.
  • This treatment strategy potentially reduces reperfusion delays compared to PCI.

Conclusions:

  • A sequential combination of tissue-type plasminogen activator and prourokinase presents a more effective treatment for AMI and ischemic stroke.
  • This fibrinolytic approach offers a promising alternative to PCI, particularly for specific clot types and reducing reperfusion times.

Keywords:
Acute myocardial infarctionPercutaneous coronary interventionProurokinaseTissue-type plasminogen activatorUrokinase

More Related Videos

Induction and Assessment of Ischemia-reperfusion Injury in Langendorff-perfused Rat Hearts07:58

Induction and Assessment of Ischemia-reperfusion Injury in Langendorff-perfused Rat Hearts

Published on: July 27, 2015

22.9K
Two-vessel Occlusion Mouse Model of Cerebral Ischemia-reperfusion07:34

Two-vessel Occlusion Mouse Model of Cerebral Ischemia-reperfusion

Published on: March 1, 2019

11.7K

Related Concept Videos

Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...